Loading...
Pimavanserin (Nuplazid™) for the treatment of Parkinson disease psychosis: A review of the literature
INTRODUCTION: Pimavanserin (Nuplazid™) is an atypical antipsychotic currently indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis. The antipsychotic effects of this new agent are believed to occur via selective inverse agonist activity at serotonin...
Saved in:
| Published in: | Ment Health Clin |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007714/ https://ncbi.nlm.nih.gov/pubmed/29955528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.09.230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|